173 related articles for article (PubMed ID: 38587542)
1. Let-7a-3p overexpression increases chemosensitivity to carmustine and synergistically promotes autophagy and suppresses cell survival in U87MG glioblastoma cancer cells.
Bahojb Mahdavi SZ; Pouladi N; Amini M; Baradaran B; Najafi S; Vaghef Mehrabani S; Yari A; Ghobadi Alamdari S; Mokhtarzadeh AA
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38587542
[TBL] [Abstract][Full Text] [Related]
2. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis.
Rezaei T; Hejazi M; Mansoori B; Mohammadi A; Amini M; Mosafer J; Rezaei S; Mokhtarzadeh A; Baradaran B
Eur J Pharmacol; 2020 Dec; 888():173483. PubMed ID: 32810491
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
[TBL] [Abstract][Full Text] [Related]
4. The Simultaneous Effects of miR-145-5p and hsa-let-7a-3p on Colorectal Tumorigenesis: In Vitro Evidence.
Mozammel N; Baghbani E; Amini M; Jodeiry Zaer S; Baghay Esfandyari Y; Tohidast M; Hosseini SS; Rahmani SA; Mokhtarzadeh A; Baradaran B
Adv Pharm Bull; 2024 Mar; 14(1):231-240. PubMed ID: 38585468
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Baicalin with Knockdown of
Paul-Samojedny M; Liduk E; Kowalczyk M; Borkowska P; Zielińska A; Suchanek-Raif R; Kowalski J
Curr Pharm Biotechnol; 2023; 24(5):686-697. PubMed ID: 35761505
[TBL] [Abstract][Full Text] [Related]
8. Positive regulation of innate immune response by miRNA-let-7a-5p.
Ueta M; Nishigaki H; Komai S; Mizushima K; Tamagawa-Mineoka R; Naito Y; Katoh N; Sotozono C; Kinoshita S
Front Genet; 2022; 13():1025539. PubMed ID: 36685889
[No Abstract] [Full Text] [Related]
9. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.
Esfandyari YB; Doustvandi MA; Amini M; Baradaran B; Zaer SJ; Mozammel N; Mohammadzadeh M; Mokhtarzadeh A
Reprod Sci; 2021 Jul; 28(7):2036-2049. PubMed ID: 33569751
[TBL] [Abstract][Full Text] [Related]
12. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Meneses García A; Hernández De La Cruz ON; Astudillo-De La Vega H; Isla-Ortiz D; Marchat LA; Salinas-Vera YM; Carlos-Reyes Á; López-González S; Ramos-Payan R; López-Camarillo C
Oncol Rep; 2018 Jun; 39(6):3086-3094. PubMed ID: 29658612
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo anticancer activities of Antrodia salmonea through inhibition of metastasis and induction of ROS-mediated apoptotic and autophagic cell death in human glioblastoma cells.
Lin YP; Hseu YC; Thiyagarajan V; Vadivalagan C; Pandey S; Lin KY; Hsu YT; Liao JW; Lee CC; Yang HL
Biomed Pharmacother; 2023 Feb; 158():114178. PubMed ID: 36916401
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
15. Caffeine inhibits the growth of glioblastomas through activating the caspase-3 signaling pathway in vitro.
Liu JD; Song LJ; Yan DJ; Feng YY; Zang YG; Yang Y
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3080-8. PubMed ID: 26367732
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression.
Liu C; Chen Z; Fang M; Qiao Y
Transl Cancer Res; 2019 Sep; 8(5):1763-1771. PubMed ID: 35116927
[TBL] [Abstract][Full Text] [Related]
17. [Proanthocyanidins inhibit pancreatic cancer AsPC-1 cell growth and migration through up-regulation of let-7a].
Ma J; Fang B; Ma C; Pang H; Zeng F; Xia J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1110-5. PubMed ID: 26277505
[TBL] [Abstract][Full Text] [Related]
18. Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells.
Xie YL; Yang YJ; Tang C; Sheng HJ; Jiang Y; Han K; Ding LJ
Clin Transl Oncol; 2014 Oct; 16(10):898-905. PubMed ID: 24643702
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Let-7d-3p Contributes to Cardiac Protection via Targeting HMGA2.
Wong LL; Saw EL; Lim JY; Zhou Y; Richards AM; Wang P
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934671
[TBL] [Abstract][Full Text] [Related]
20. Let-7a inhibits Bcl-xl and YAP1 expression to induce apoptosis of trophoblast cells in early-onset severe preeclampsia.
Zha W; Guan S; Liu N; Li Y; Tian Y; Chen Y; Wang Y; Wu F
Sci Total Environ; 2020 Nov; 745():139919. PubMed ID: 32721616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
